Abstract:Praziquantel (PZQ) is the drug recommended by the World Health Organization for treatment of schistosomiasis. However, the treatment of children with PZQ tablets is complicated due to difficulties to adapt the dose and the extremely bitter taste of PZQ. For this reason, poly (methyl methacrylate) nanoparticles loaded with Praziquantel (PZQ-NP) were developed for preparation of a new formulation to be used in the suspension form. For this reason, the main aim of the present study was to evaluate the pharmacokinetic (PK) profile of PZQ-NP, through HPLC-MS/MS assays. Analyses were performed with an Omnisphere C18 column (5.0 μm×4.6 mm×150.0 mm), using a mixture of an aqueous solution containing 0.1 wt% of formic acid and methanol (15:85-v/v) as the mobile phase at a flow rate of 0.800mL/min. Detection was performed with a hybrid linear ion-trap triple quadrupole mass spectrometer with multiple reactions monitoring in positive ion mode via electrospray ionization. The monitored transitions were m/z 313.18>203.10 for PZQ and m/z 285.31>193.00 for the Internal Standard. The method was validated with the quantification limit of 1.00 ng/mL, requiring samples of 25 μL for analyses. Analytic responses were calibrated with known concentration data, leading to correlation coefficients (r) higher than 0.99. Validation performed with rat plasma showed that PZQ was stable for at least 10 months when stored below -70 °C (long-term stability), for at least 17 h when stored at room temperature (RT, 22 °C) (short-term stability), for at least 47 h when stored at room temperature in auto-sampler vials (post-preparative stability) and for at least 8 successive freeze/thaw cycles at -70 °C. For PK assays, Wistar rats, weighing between 200 and 300 g were used. Blood samples were collected from 0 to 24 h after oral administration of single doses of 60 mg/kg of PZQ-NP or raw PZQ (for the control group). PZQ was extracted from plasma by liquid-liquid extraction with terc-butyl methyl ether. The values obtained for maximum concentration (C(max)) and area under curve (AUC) for the PZQ-NP group were about 3 times smaller than the respective values obtained for the control group. However, the time for achieving maximum concentration (T(max)), the elimination constant (Ke) and the half-life time of elimination (T(½β)) were not statistically different. These results suggest that PZQ absorption is probably the rate-limiting step for obtainment of better PK parameters for PZQ-NP. Thus, further studies are needed to understand both the PZQ-NP absorption mechanisms and the drug diffusion process through the polymer matrix in vivo, in order to improve the PZQ-NP release profile.

Formulation, Characterization and Pharmacokinetics of Praziquantel-Loaded Hydrogenated Castor Oil Solid Lipid Nanoparticles

Preparation and Physicochemical Properties of Solid Lipid Nanoparticles Containing Praziquantel

Preparation and in vitro-in vivo Evaluation of Long-circulating Solid Lipid Nanoparticles Loaded with Praziquantel

Preparation of Solid Lipid Nanoparticles Containing Praziquantel

Solid Lipid Nanoparticle Suspension Enhanced the Therapeutic Efficacy of Praziquantel Against Tapeworm

Preclinical pharmacokinetic evaluation of praziquantel loaded in poly (methyl methacrylate) nanoparticle using a HPLC-MS/MS

Effect of Peg2000 on Drug Delivery Characterization from Solid Lipid Nanoparticles

Design and Optimization of Thermosensitive Nanoemulsion Hydrogel for Sustained-Release of Praziquantel

Dissolution and Oral Bioavailability Enhancement of Praziquantel by Solid Dispersions

Formulation, Development and Evaluation of Praziquantel Loaded Nanosponges (PZQ-Nsgs) by Using Factorial Design

Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier

Preparation and Drug Release Study of Novel Nanopharmaceuticals with Polysorbate 80 Surface Adsorption

Preparation and Evaluation of Ofloxacin-Loaded Palmitic Acid Solid Lipid Nanoparticles

Enhancement of Gastrointestinal Absorption of Quercetin by Solid Lipid Nanoparticles.

Study on Preparation,release in Vitro and Pharmacodynamics of the Oral Propylene Glycol Alginate Sodium Sulfate(pss) Nanoparticles

Preparation, Characterization And Drug Release Of Biodegradable Solid Lipid Nanoparticles

Studies on Preparation of Quercetin Solid Lipid Nanoparticles and Oral Absorption in Mice

Study on formulation and preparation of chitosan chloride coated hydroxycamptothecin nanoliposomes

Preparation, Characterization, and in Vitro Release of Chloramphenicol Loaded Solid Lipid Nanoparticles

Preparation and Evaluation of Lecithin/zein Hybrid Nanoparticles for the Oral Delivery of Panax Notoginseng Saponins.

Tunable Polymeric Mixed Micellar Nanoassemblies of Lutrol F127/Gelucire 44/14 for Oral Delivery of Praziquantel: A Promising Nanovector against Hymenolepis nana in Experimentally-Infected Rats